Results 181 to 190 of about 470,796 (264)

Achondroplasia management in the era of targeted therapies: a meta-analysis of C-type natriuretic peptide analogs. [PDF]

J Endocr Soc
Kamrul-Hasan ABM, Uday S, Nagendra L, Dutta D, Bhattacharya S, Pappachan JM, Ashraf AP.   +6 more
europepmc   +1 more source

Obesity Subtypes and Longitudinal Trajectories of Function Over Seven Years of Follow‐Up: Data From the Multicenter Osteoarthritis Study

Arthritis Care &Research, EarlyView.
Objective Obesity, defined by body mass index (BMI) ≥30 kg/m2, is a risk factor for functional limitations in people with knee osteoarthritis (OA). However, function varies among such individuals. Our objective was to evaluate the implications of obesity subtypes on longitudinal patterns of physical functioning in people with or at risk for knee OA ...
Kristine Godziuk, Sarah Tilley, Michael LaValley, Michael C. Nevitt, Cora E. Lewis, James C. Torner, Tuhina Neogi, for the Multicenter Osteoarthritis Study Group   +7 more
wiley   +1 more source

Olfactory Training for COVID-19–Related Smell Loss: The SMELL Trial

Heim B, De Cleene N, Jagusch F, Peball M, Cerejo C, Schmutzhard J, Löffler-Ragg J, Göbel G, Djamshidian A, Weiss G, Seppi K.   +10 more
europepmc   +1 more source

True triaxial hydraulic fracturing experiments and FDEM simulation study of coal-measure rock strata. [PDF]

Sci Rep
Ma J, Dong G, Wang H, Li X.
europepmc   +1 more source

The Lupus Damage Index Revision Program: Results From the Item Generation and Reduction Phases

Arthritis Care &Research, EarlyView.
Objective A data‐driven and expert/patient consensus‐based project to develop a revised Systemic Lupus International Collaborating Clinics (SLICC)/American College of Rheumatology (ACR) Damage Index (SDI) is under way supported by SLICC, ACR, and the Lupus Foundation of America. Our objective is to report the item generation and reduction phase results
Burak Kundakci, Megan R. W. Barber, Ann E. Clarke, Sindhu R. Johnson, Anselm Mak, Hermine I. Brunner, Murat Inanc, Rosalind Ramsey‐Goldman, Guillermo Ruiz‐Irastorza, Ellen M. Ginzler, John G. Hanly, Alexandra Legge, Cynthia Aranow, Laurent Arnaud, Nathalie Costedoat‐Chalumeau, Dafna D. Gladman, Søren Jacobsen, Michelle Petri, Clovis A. Silva, Évelyne Vinet, Alexandre E. Voskuyl, SDI Revision Literature Review Groups, SDI Revision Delphi Panel, SDI Revision Item Reduction Committee, SDI Revision Clinical Domain Groups, Ian N. Bruce   +25 more
wiley   +1 more source

Massively parallel bead-free force spectroscopy with fluorescence. [PDF]

Sci Adv
Yasunaga AB, Riopel R, Bakker DTR, Raghu D, Yang M, Li ITS.   +5 more
europepmc   +1 more source

Impact of Six‐Month Monitoring Compared to Three‐Month Monitoring of Laboratories During Methotrexate Therapy

Arthritis Care &Research, EarlyView.
Objective To evaluate whether extending the American College of Rheumatology–recommended monitoring interval for complete blood count and liver function tests in patients receiving methotrexate (MTX) affects timely detection of medication‐related toxicity.
Spencer Simko, Ray Zhang, Sohini Mukherjee, Puneet Bajaj, Bonnie L. Bermas   +4 more
wiley   +1 more source

From empirical to analytical: synergizing robotic assistance with customized implants for superior TKA outcomes. [PDF]

J Orthop Surg Res
Zheng H, Wang Z, Zhang J, Wu K, Zheng J, Shao H, Zhou Y.   +6 more
europepmc   +1 more source

Employment Trajectories of Patients With Systemic Lupus Erythematosus and Factors Driving Transitions Between States

Arthritis Care &Research, EarlyView.
Objective Systemic lupus erythematosus (SLE) significantly impacts employment capacity. This study aimed to investigate the impact of burden of disease activity, damage, and treatment on employment outcomes and transitions in patients with SLE. Methods Using data from a single center, we analyzed employment transitions, adjusted mean disease activity ...
Javier Mencia‐Ledo, Zahi Touma, Laura Whittall Garcia, Dafna D. Gladman, Behdin Nowrouzi‐Kia   +4 more
wiley   +1 more source

Mutasynthesis and Antibiotic Activity of Mupirocin Analogues. [PDF]

Chembiochem
Husain SM, Wang L, Han LC, Bowen JI, Song Z, de Courcy-Ireland F, Winter AJ, Simpson TJ, Race PR, Spencer J, Crump MP, Willis CL.   +11 more
europepmc   +1 more source